J
Power Law company profile
Janssen Vaccines
Biotech & Life Sciences · Leiden, Netherlands · Founded 2000 · IPO 2000 Unicorn
Global footprint
Where Janssen Vaccines has talent and traffic
Web traffic by country
33K
monthly visits
across markets
across markets
🇺🇸 United States80.3%
🇵🇱 Poland18.2%
🇨🇦 Canada0.9%
Patent intelligence
$7.1B patent portfolio · 3,963 active families
Total estimated portfolio value via Dealroom Patent Intelligence (Patsnap), with quality scores compared against same-sector peers.
Estimated portfolio value
$7.1B
27.9× the top peer Zealand Pharma ($254M)
3,963 active patent families
Where Janssen Vaccines innovates
Biomedical engineeringTGE VACCINEMolecular biologyVirosomePharmaceutical Substances
Above peer median on Legal, Strategic
Quality vs same-sector peers
Janssen Vaccines on the five Patsnap quality dimensions
Janssen Vaccines in orange. Same-sector peers are the top filers by total patent value. All scores 0–100; higher is stronger.
Compare against
Patent quality scores (0–100)
Source: Dealroom Patent Intelligence · PatsnapTech-focus vs peers
Where Janssen Vaccines concentrates inside the peer cluster
Axes are the most-shared Patsnap topics across Janssen Vaccines and its top peers. Each polygon's reach on an axis = how prominent that topic is in that company's portfolio (#1 topic = 100, #10 = 10, absent = 0).
Compare against
Top-topic prominence (rank inverted, 0–100)
Source: Dealroom Patent Intelligence · Patsnap top-10 topics per companySee Janssen Vaccines on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.